ASH2L and hepatocellular carcinoma: Furthermore, the size of liver tumors and the extent of HCC progression were significantly lower in mutant mice than in WT mice (Figure S2A, Supporting Information), indicating that lactylation‐modified ASH2L promoted the malignant progression of HCC.